Login to Your Account

Valuation Under Pressure

Seeking Ways to Bridge the Deal-Making Valuation Gap

By Trista Morrison

Monday, October 31, 2011

While deal-makers remain optimistic about the pace of business development in the drug industry, external forces continue to drive a wedge between the valuation expectations of buyers and sellers – leading to an increase in contingent value rights, earn-outs and other structured mechanisms that can require some fancy negotiating footwork.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription